MALAT1 and glioma: In addition to SOX-2, MALAT1 downregulation has shown inhibitory effects on the expression of Nestin (another stemness marker) and proliferation of glioma stem cell lines by activating the ERK/MAPK signaling pathway, which is a key pathway in tumor development (15, 31).